Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. José-Luis Zamorano
Ms Adriana Saltijeral
Prof. Leopoldo Perez de Isla,
3D transesophageal echocardiography (3D-TEE) has rapidly become the gold standard in the evaluation of every patient with a valve disease. This new technique is both easy to use and results to analyse and provides a new window for heart evaluation, not only for the cardiologist, but also for other medical doctors involved in the management of patients suffering from heart diseases, such as cardiac surgeons.
For the time being, only 3D-TEE probes are commercially available. This probe uses more than 2.500 piezoelectric that allow it to work in two different but complementary ways: 1) as a standard transesophageal transducer, able to obtain 2D, M-mode, Doppler… as when obtaining them with a normal 2D probe (Figure 1). But the same 3D image modalities can also be obtained with a transthoracic 3D probe: x-Plane imaging (two simultaneous planes), Live 3D (real time 3D images), Live 3D Zoom (Figure 2) and 3D Full Volume (four to seven heart cycles are used to obtain a large volume image) and 3D Color Full Volume (several heart cycles are used to obtain a volume with color Doppler information) become possible to acquire. The most frequent limitations of this new system are related to the quality of the transesophageal acoustic window of the patient and to the low temporal resolution it provides. Aproximate cost of this system is 180.000 euros and the cost of the probe 45.000 euros. Aproximate cost of a 2D TEE probe is 12.000 euros. Cardiologysts are waiting for new devices in the near future and this fact probably decrease the price. Thus, this technique could be affordable for a wide number of practicionners.
Summarising the most common indications to perform a 3D-TEE, we may say that it is useful in the following situations:
Figure 1: 3D-TEE probe may also be used as a conventional 2D-TEE probe. In this figure we can see a mitral valve prolapse.
Figure 2: Ostium secundum atrial septal defect obtained by means of 3D-TEE zoom technique. This view was obtained from the left atrium lateral wall. The septal defect can be see as a « black hole » in the image.
Figure 3: Aortic valve 3D-TEE image. The three aortic leaflets can be seen during systole in this image.
Figure 4: Mitral valve prolapse evaluation by using 3D-TEE imaging. Mitral valve prolapse evaluation is one of the most common indications for transesophageal 3D echocardiography.
3D-TEE is one of the most significant advances in cardiac imaging from recent years. This new technique is improving the diagnostic accuracy and the clinical management of hundreds of patients all around the world.
1. Scohy TV, Soliman OI, Lecomte PV, McGhie J, Kappetein AP, Hofland J, Ten Cate FJ. Intraoperative real time three-dimensional transesophageal echocardiographic measurement of hemodynamic, anatomic and functional changes after aortic valve replacement. Echocardiography. 2009 Jan;26(1):96-9. Epub 2008 Nov 7. 2. Pepi M, Tamborini G, Maltagliati A, Galli CA, Sisillo E, Salvi L, Naliato M, Porqueddu M, Parolari A, Zanobini M, Alamanni F. Head-to-head comparison of two- and three-dimensional transthoracic and transesophageal echocardiography in the localization of mitral valve prolapse. J Am Coll Cardiol. 2006 Dec 19;48(12):2524-30. 2. García-Orta R, Moreno E, Vidal M, Ruiz-López F, Oyonarte JM, Lara J, Moreno T, García-Fernández MA, Azpitarte J. Three-dimensional versus two-dimensional transesophageal echocardiography in mitral valve repair. J Am Soc Echocardiogr. 2007 Jan;20(1):4-12. 3. Langerveld J, Valocik G, Plokker HW, Ernst SM, Mannaerts HF, Kelder JC, Kamp O, Jaarsma W. Additional value of three-dimensional transesophageal echocardiography for patients with mitral valve stenosis undergoing balloon valvuloplasty. J Am Soc Echocardiogr. 2003 Aug;16(8):841-9. 4. Sugeng L, Shernan SK, Weinert L, Shook D, Raman J, Jeevanandam V, DuPont F, Fox J, Mor-Avi V, Lang RM. Real-time three-dimensional transesophageal echocardiography in valve disease: comparison with surgical findings and evaluation of prosthetic valves. J Am Soc Echocardiogr. 2008 Dec;21(12):1347-54. Epub 2008 Oct 10. 5. Jaber WA, White RD, Kuzmiak SA, Boyle JM, Natale A, Apperson-Hansen C, Thomas JD, Asher CR. Comparison of ability to identify left atrial thrombus by three-dimensional tomography versus transesophageal echocardiography in patients with atrial fibrillation. Am J Cardiol. 2004 Feb 15;93(4):486-9. 6. Karakus G, Kodali V, Inamdar V, Nanda NC, Suwanjutah T, Pothineni KR. Comparative assessment of left atrial appendage by transesophageal and combined two- and three-dimensional transthoracic echocardiography. Echocardiography. 2008 Sep;25(8):918-24. 7. Roldán FJ, Vargas-Barrón J, Vázquez-Antona C, Castellanos LM, Erdmenger-Orellana J, Romero-Cárdenas A, Martínez-Ríos MA. Three-dimensional transesophageal echocardiography of the atrial septal defects. Cardiovasc Ultrasound. 2008 Jul 18;6:38. 8. Biner S, Rafique AM, Kar S, Siegel RJ. Live three-dimensional transesophageal echocardiography-guided transcatheter closure of a mitral paraprosthetic leak by Amplatzer occluder. J Am Soc Echocardiogr. 2008 Nov;21(11):1282.e7-9. Epub 2008 Aug 15. 9. Scohy TV, Lecomte PV, McGhie J, Meijer R, Gommers D, Hofland J, Ten Cate FJ. Intraoperative real time three-dimensional transesophageal echocardiographic evaluation of right atrial tumor. Echocardiography. 2008 Jul;25(6):646-9.
Leopoldo Pérez de Isla, Adriana Saltijeral and José Zamorano Instituto Cardiovascular Hospital Clínico San Carlos. Madrid. Spain
Correspondence: Leopoldo Pérez de Isla Unidad de Imagen Cardiovascular Hospital Clínico San Carlos Plaza Cristo Rey 28040-Madrid, Spain Tel: 0034913303290 Fax: 0034913303290 email@example.com
© 2017 European Society of Cardiology. All rights reserved